Implant grade silicones, while inherently biocompatible, are rigorously tested and scrutinized to last many years within the ...

The funding is set to be used to launch a new a multi-centre, blinded, randomised clinical trial designed to test the ...

Implantable Cardioverter-Defibrillator fails to reduce all cause mortality among patients with chronic Chagas cardiomyopathy ...

ShiraTronics announced today that it closed a $66 million Series B financing round to support its Migraine Therapy System.

As development of the technology accelerates, countries are weighing the costs and benefits of how they regulate it.

Iota Biosciences, anAstellas subsidiary, announced that it received FDA investigational device exemption (IDE) for its ...

Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...

Our sleep needs change over the course of our lifetimes—from 17 hours a day as a newborn, to up to 12 hours as a schoolkid, ...

PITTSBURGH – A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research ...

Biosciences, Inc., a wholly-owned subsidiary of Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has ...

MarketThe global implantable collamer lens (ICL) market is poised for substantial growth over the next decade, driven by the increasing popularity of minimally invasive surgical procedures. According ...

The number of patients carrying ICDs is ever increasing, so these devices are present in numerous medical circumstances and have to be evaluated by physicians who do not have expert knowledge of ...